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Purpose: The leaves of Erigeron floribundus (Kunth) Sch. Beep. or (syn: Conyza sumatrensis (Retz) 
E.K. Walker) (Asteraceae) are used by some traditional healers in West Africa in HIV/AIDS therapy. The 
purpose of this study was to assess the immune-boosting properties of the aqueous leaf extract of 
Erigeron floribundus (Ef) by monitoring blood markers of cellular immunity in rabbit. 
Methods: Two sets each of five groups (six rabbits per group) were used in this study. The groups in 
the first set each received intraperitoneally a single dose of Ef (25, 50, 75 or 100 mg/kg) or 0.9 % NaCl 
(control). The groups in the second set received methylprednisolone (15 mg/kg, MP15) and mixtures of 
MP15 with Ef (50, 75 or 100 mg/kg), MP15 or isoprinosine 50 mg/kg (Ip50, reference standard). Whole 
blood was collected in EDTA tubes from the marginal vein of the rabbit ear on Days 0, 3, 9, 15 and 21 
after administration for the determination of CD4+ count by flow cytometry, and also of neutrophils and 
total lymphocytes in the blood.  
Results: Each plant extract dose tested (50, 75 and 100 mg/kg) induced a significant increase in 
neutrophils (p < 0.001), total lymphocytes and TCD4+ (p < 0.0001) from the 3rd to 15th day after 
administration, compared to control (0.9 % NaCl). Furthermore, the same test extract doses significantly 
reversed the immunosuppressive effect of methylprednisolone (p < 0.001) to the same extent as 
isoprinosine.  
Conclusion: The aqueous extract of the leaves of Erigeron floribundus stimulated the increase of 
neutrophils, total lymphocytes and TCD4+ in rabbit blood and thus provides some justification for its use 
in the traditional treatment of AIDS.  
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INTRODUCTION 
 
It is well known that infections induce 
decrease in immune response through the 
inhibition of CD4+ and CD8+ cells [1]. The 
main cells affected by this immunosuppre-
ssive action are the lymphocytes and 
neutrophil. The neutrophils are known as 
dedicated phagocytic cells of the innate 
immune system. These cells represent up to 
70 % of the white blood cells of circulating 
blood. They are recruited to the sites of 
infections. There, they exert their phagocytic 
activity, destroying germs with reactive 
oxygen species and bactericidal proteins or 
other potent molecules. TCD4+ cells have a 
major role in the immune system, in which a 
decrease implies a weakened immune 
system due to infection [2]. Hence, decrease 
in the CD4+ count in some viral diseases, 
such as HIV [3], is an indication for 
antiretroviral (ARV) therapy [4]. In other 
pathological conditions such as cancer and 
autoimmune diseases, decrease in T 
lymphocytes, predominantly CD4+ cells, 
indicates weakness of the immune system 
[5]. In contrast, in the case of organ 
transplants, immunosuppressive treatment 
with a glucocorticoid (such as methylpred-
nisolone), cytotoxic drugs and antibodies are 
administered after transplanttation to prevent 
graft rejection [6].  
 
Immunosuppressive diseases such as 
HIV/AIDS may require the addition of 
immunostimulator in combination with 
antiretrovirals (ARVs) on the one hand or as 
a monotherapy, on the other hand, to avoid 
taking ARVs. Indeed, ARV drugs have 
several side effects including skin reaction, 
fatigue, nausea, diarrhea, fever, insomnia [7] 
which can be stressful to patients. It is, 
therefore, necessary to strengthen the 
immune system by stimulating the production 
of CD4+ T lymphocytes.  
 
In West Africa, the plant, Erigeron floribundus 
(Asteraceae), is used traditionally in AIDS 
therapy. In addition, Asongalem et al [8] have 
reported the peripheral and central analgesic 
properties as well as the anti-inflammatory 
activity of the aqueous extract of Erigeron 
floribundus. Tra Bi et al [9] has also 
demonstrated the antifungal activity of the 
dichloromethane extract of the plant extract. 
 
The objective of this study was to evaluate 
the immunostimulatory property of the 




Plant material  
 
The leaves of Conyza sumatrensis (Retz.) E. 
Walker Syn. Erigeron floribundus 
(Asteraceae) were collected from the tropical 
forest of southeastern part of Cote d’Ivoire in 
January 2009. The plant material was 
identified and authenticated by Pr Laurent 
Ake-Assi of the Department of Botany, 
University of Cocody, Abidjan, Côte d’Ivoire. 
A voucher specimen (no. 5392) of the plant 
material was deposited in the herbarium of 
the National Floristique Center of the 
University of Cocody-Abidjan, Côte d’Ivoire.  
 
Preparation of aqueous extract 
 
The leaves were sorted, washed, dried at 
ambient temperature and then ground into 
fine powder. Two hundred grams (200 g) of 
this powder were macerated in 1 L of distilled 
water for 24 h and filtered, first through a soft 
fabric and Whatman filter paper No.1. The 
filtrate was dried in an oven at 50 °C. The dry 
extract was dissolved in distilled water prior 




Rabbits of the species Oryctolagus cuniculus, 
aged between 3 and 4 months and weighing 
1.5 ± 0.3 kg were used. They were provided 
by a breeding company and were 
acclimatized at 25 °C in a 12h light/12 h dark 
cycle in the pet room of the laboratory for 14 
days prior to the experiment. The animals 
were given feed (FACI
®
 Company, Abidjan, 
Cote d’Ivoire) for rabbits and tap water ad 
Yapo et al 
Trop J Pharm Res, April 2011;10 (2): 189 
libitum. The equipment, including handling 
and sacrificing of the animals were in 
accordance with European Council 
Legislation 87/609/EEC for the protection of 




The immunosuppressive agent used was 






As for the immune reference, we used the 




To determine the effect of the plant extract on 
total lymphocyte, CD4+ and neutrophils, two 
types of experiments were performed with 
two sets of 5 groups of 6 rabbits each. The 
first set received intraperitoneally a single 
dose of the extract (25, 50, 75 or 100 mg/kg) 
for groups 1a – 4a, and 0.9 % NaCl for group 
5a (control). The second set received 
intraperitoneally methyprednisolone (15mg/ 
kg, MP15) alone (group 1b) or MP15 plus the 
extract (50, 75 or 100 mg/kg) for groups 2b – 
4b, and MP15 plus isoprinosine (50mg/kg, 
Ip50) for group 5b [11]. In each case, a blood 
sample was taken from the marginal vein of 
the rabbit ear on the first day (D0) before the 
injection of the drugs/extract, and then 
weekly for 3 weeks, and kept in EDTA tubes 
to prevent blood coagulation. The blood was 
used the same day for the determination of 
total lymphocytes, CD4+ T-lymphocytes and 
neutrophils. Prior to each sampling, the 
animals were weighed on a balance (Ametek 
Chatillon
®
, USA).  
 
Determination of lymphocytes, neutrophils 
and TCD4+ lymphocytes 
 
Total lymphocyte count and neutrophil blood 
count was carried out on a portion of the 
whole blood using a hemogram (Sysmex XT-
2000i
®
, Framingham, USA). The other portion 
of whole blood was used to determine the 
level of CD4+ T lymphocytes by the method 
of Becton Dickinson (BD) Tritest (CD3 PerCP 
FITC/CD4 PE/CD45) with a flow cytometer 
(BD FACS Calibur
®
, (New Jersey, USA).  
 
Statistical analysis  
 
Statistic analysis was undertaken with 
GraphPad Prism V5.01 software (GraphPad, 
Washington, USA). Groups of data were 
compared by one-way analysis of variance 
(ANOVA). Due to the small population size, 
the non-parametric Dunnett test was 
performed to assess differences between the 
control group and the other groups. For the 
comparison of variance between the groups, 
we used the non-parametric test of Kruskall-
Wallis. Differences were considered 




Effect of the extract (Ef) on neutrophils  
 
Figure 1 showed that the injection of 
increasing doses of the extract (Ef) to the 
rabbits induced a significant increase in 
neutrophil count on Day 3 from (1.49 ± 0.29) 
x 10
3
 to (2.22 ± 0.17) x 10
3
 cells/µl (p < 
0.001) for Ef50, (2.02 ± 0.2) x 10
3
cells/µl (p < 
0.05) for Ef75, and (2.12 ± 0.24) x 10
3
 cells/µl 
(p < 0.001) for Ef100. However, on Day 9, 
neutrophil levels were (1.49 ± 0.29) x 10
3
 to 
(2.52 ± 0.15) x 10
3 
cells/µl (p < 0.001) and 
(2.62 ± 0.14) x 10
3
 cells/µl (p < 0.001) for 
Ef50 and Ef75, respectively.  
 
Effect of combined extract and methyl-
prednisolone/isoprinosine on neutrophil 
count  
 
Figure 2 shows that while methylprednisolone 
(MP, 15mg/kg) alone had no effect on the 
count of neutrophils, combining it with the 
extract increased neutrophil count to as high 
as (3.02 ± 0.27) x 10
3
 cells/µl (p<0.001) on 
Day 9, (2.50 ± 0.16) x 10
3
 cells/µl (p < 0.001) 
on Day 3 and (2.92 ± 0.26) x 10
3
 cells/µl (p< 
0.05) on Day 15. However, there were no 
significant differences between neutrophil 
levels when the extract was administered 
alone and when it was combined with MP on 
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Days 3 and 9. Similarly, Ip50 induced a 
significant increase of neutrophils count from 
Days 3 to 21 with a high peak at Day15 (3.01 
to 0.77) x 10
3
 cells/µl (p < 0.001) despite the 
presence of MP15 (see Fig 2).  
 

































Figure 1: Variation of the neutrophils count with time 
following administration of Erigeron floribundus  
Key:         = NaCl 0.9%;         = Ef 25mg/kg BW (Ef25);      
     
   = Ef 50mg/kg BW (Ef50);        = Ef 75mg/kg BW (Ef75);
     
Ef   = 100mg/kg BW (Ef100)  *p < 0.05; **p < 0.001. 
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(MP, 15mg/kg) alone had no effect on the 
count of neutrophils, combining it with the 
extract increased neutrophil count to as high 
as (3.02 ± 0.27) x 10
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Day 9, (2.50 ± 0.16) x 10
3
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 cells/µl (p < 0.001) despite the 
presence of MP15 (see Fig 2).  
 































Figure 2: Variation of the neutrophils count by Ef and Ip 
on neutrophil count following administration of 
methylprednisolone (MP)  
 
 Key:            = NaCl 0.9 %;     = MP15;             
= MP15 + Ef50;    = MP15 + Ef75 
     = MP15 + Ef100;         = MP15 + Ip50; *p <  
 
0.05; **p < 0.001. 
 
Effect of extract on lymphocyte count  
 
Figure 3 illustrates that the extract induced a 
significant increase in total lymphocyte count 
on Day 3 from 1753 ± 64 to 2056 ± 81 cells/µl 
(p < 0.0001) for Ef75, to 1958 ± 54 cells/µl (p 
< 0.001) for Ef100, and to 1894 ± 169 cells/µl 
(p < 0.05) for Ef50. These increases were 
reversed by Day 21.  
 






























Figure 3: Effect of Erigeron floribundus extract on total 
lymphocytes count  
 
Key: ● = Control (0.9 % NaCl); ■ = Ef 25 mg/kg (Ef25); □ 
= Ef 50 mg/kg (Ef50); ▲ = Ef 75mg/kg (Ef75); ∇ = Ef 
100mg/kg (Ef100); n=6);  *p < 0.05, **p < 0.001 and  ***p 
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Effect of Ef/MP mixture on total lympho-
cyte count  
 
Figure 4 shows that while MP15 produced a 
significant decrease (p < 0.0001) in the level 
of total lymphocytes from 2715 ± 88 to 2250 
± 132 cells/µl (Day 3) and to 2313 ± 65.06 
cells/µl (Day 9), in contrast, Ef/MP mixtures 
induced a significant increase in total 
lymphocytes.  


































Figure 4: Effect of Ef and Ip on total lymphocytes 
following the administration of MP. 
 Key:        = NaCl 0.9 %;     = Ef 25mg/kg BW 
(Ef25);     = Ef 50mg/kg BW (Ef50);    = Ef 
75mg/kg BW (Ef75);    == Ef 100mg/kg BW 
(Ef100)    
*p < 0.05, **p < 0.001 and ***p < 0.0001.  
 
The significant difference between the 
average count of total lymphocytes induced 
by the mixtures of Mp15+Ip50; Mp15+Pb50, 
Pb75 or Pb100 is expressed by a (p < 
0.0001); b (p < 0.001; c (p<0.05). The 
significant difference between the average 
level of total lymphocytes induced by MP15 
and mixtures MP15+Ef50, Ef75 or Ef100 is 
expressed by α (p < 0.0001); β (p < 0.001; 
and γ (p < 0.05 
 
Effect of Ef on TCD4+ count 
 
Increasing doses of the extract (Ef) ≥ 
50mg/kg induced a significant increase in 
total blood TCD4+ from Day 3 to 15, as Fig. 5 
shows, with Ef50 and Ef100 producing 146 ± 
6 cells/µl (p < 0.05) and 157 ± 4 cells/µl (p < 
0.001), respectively, on Day 3, compared to 
128 ± 5 cells/µl on Day 0. The peak for Ef75 
(157 ± 2 cells/µl, p < 0.001) was reached on 
Day 9.  
 






















Figure 5: Effect of Erigeron 
floribundusextract on TCD4+ count  
 
Key: ● = Control (0.9 % NaCl); ■ = Ef 25 mg/kg (Ef25); □ 
= Ef 50 mg/kg (Ef50); ▲ = Ef 75mg/kg (Ef75); ∇ = Ef 
100mg/kg (Ef100); n = 6)  
 
Effect of Ef/MP mixture on TCD4+ count 
 
Figure 6 shows that MP15 induced a 
significant decrease in CD4+ count on Day 3 
from 125 ± 3 to 106 ± 4 cells/µl (p < 0.001) 
and on Day 9 from 125 ± 3 to 112 ± 5 cells/µl 
(p < 0.05). In contrast, Ef/MP mixtures 
increased significantly (p < 0.001, p < 0.0001) 
the level of CD4+ count. Ip50/MP15 mixture 
increased significantly (p < 0.05) TCD4+ 
count on Day 3 (125 ± 3 to 140 ± 5 cells/µl).  
 


































Figure 6: Effect of Erigeron floribundus 
extract on TCD4+ count folowing 
administration of MP 
 Key:            = NaCl 0.9 %;  = Ef 25mg/kg 
BW (Ef25); = Ef 50mg/kg BW (Ef50;)               
         = Ef 75mg/kg BW (Ef75);   = Ef 
100mg/kg BW (Ef100) 
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The levels of significance difference are 
expressed by: *p < 0.05 and **p < 0.001. The 
significant difference between the average 
count of total lymphocytes induced by the 
mixtures of Mp15+Ip50; Mp15+Pb50, Pb75 or 
Pb100 is expressed by a (p < 0.0001); b (p < 
0.001; c: (p < 0.05). The significant difference 
between the average level of total 
lymphocytes induced by MP15 and mixtures 
MP15+Ef50, Ef75 or Ef100 is expressed by α 




This work has shown that the total aqueous 
extract of the leaves of Erigeron floridundus 
(Asteraceae) (Ef) increased the levels of total 
lymphocytes, neutrophils and TCD4+. 
Indeed, in addition to their role in 
inflammation via the activation of NK cells, 
neutrophils also play a crucial role in the 
immune system with regard to innate and 
acquired immunity [12]. Therefore, increasing 
their levels in peripheral blood would 
strengthen the immune system. In this 
regard, therefore, Erigeron floribundus 
stimulates the production of these cellular 
markers of immunity in circulating blood. The 
increase in total lymphocyte and neutrophil 
levels might have resulted either from the 
release of immune cells from their 
sequestration sites in lymphatic tissue, or 
following their synthesis in the bone marrow 
[13] due to stimulation by Ef. On the other 
hand, methylprednisolone induced a 
decrease in total lymphocyte and CD4+. 
According to Wong et al [14], glucocorticoids 
can suppress cell-mediated immunity by 
inhibiting the production of lymphocyte 
mediator or via reduction in the cell response 
targets of these mediators.  
 
The comparable effects of Ef and 
isoprinosine (Ip) on the immunosuppressive 
activity of MP has shown that the products 
are inhibitors of the immunosuppressive 
action of MP either on the synthesis sites or 
the site reservoirs of lymphocytes and CD4+. 
Thus, Ef would have stimulated the release of 
lymphocytes and CD4+ in the bloodstream as 
indicated by Cillari et al [15] with regard to the 
immune-potentiating effect of isoprinosine in 
protecting persons infected with HIV. 
Furthermore, it has been demonstrated that 
treatment of 43 children with respiratory 
infection with isoprinosine 50 mg/kg/day three 
times a week for six months, resulted in an 
increase in the number of lymphocytes 
TCD3+, TCD4+ and TCD8+ [11]. Also, 
administration of 50mg/kg isoprinosine to 
mice was reported to lead to a proliferation of 
normal T cells [16]. This isoprinosine-like 
effect of Ef suggests that the extract could 
increase the level of CD4+ T lymphocytes in 
immunocompromised persons.  
 
In contrast, 15mg/kg dose of MP had no 
effect on neutrophils, because according to 
Weiner et al [17], only high doses of 
intravascular MP (30 mg/kg) are capable of 
inducing neutropenia. Therefore, the 
inhibitory effect on cellular immunity by MP at 
this dose (15 mg/kg) would be lymphocytic, 
not neutrocytic. The rate of increase of 
lymphocytes in the presence of MP by Ip was 
significantly higher (p < 0.0001) than that 
induced by Ef on Day 3, when administered 
at the same concentration level (50 mg/kg), 
probably because isoprinosine is a purified 
product compared to the aqueous extract of 
Ef. According to Hadden and Wybran [18], 
isoprinosine is an antiviral agent that 
stimulates the immune cells. Thus, this 
immunopotentiating property of Ip should 
make it useful for the treatment of 
autoimmune diseases [17]. Having regard to 
the isoprinosine–like effect of Ef on immune 
cells, one might suggest that this effect could 
also have immunopotentiating activity on 





This study showed that the aqueous leaf 
extract of Erigeron floribundus (Ef) has a 
stimulating effect on the blood levels of some 
cellular markers of immunity, including 
neutrophil cells, total lymphocytes and 
TCD4+ cells. The extract inhibited the 
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immunodeficiency created with 
methylprednisolone. The extract could, thus, 
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